Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02143063 · ClinicalTrials.gov registry record · NA
Extending Long-term Outcomes Through an Adaptive Aftercare Intervention
A NA study, sponsored by UConn Health.
- Completed
- Registry status
- NA
- Development phase
- 274
- Enrollment target
NCT02143063: Completed NA study, sponsored by UConn Health.
NCT02143063 is a NA study that has completed, run by UConn Health. The registered enrollment target is 274 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (80% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02143063, a NA study, has completed, sponsored by UConn Health.
- COMPLETED
- Registry status
- NA
- Development phase
- 274 participants
- Enrollment target
Study Summary
Reinforcement interventions have pronounced effects on reducing cocaine use. This study will evaluate a novel approach in which reinforcement frequency varies by patient performance. To test efficacy, 280 patients with cocaine use disorder will be randomly assigned to: standard care, standard care plus traditional twice weekly reinforcement, or standard care plus adaptive variable interval reinforcement.
Primary Outcome
Longest duration of consecutive cocaine-negative urine toxicology tests
Interventions
- BEHAVIORAL standard care
- BEHAVIORAL prize contingency management on a traditional twice weekly schedule for cocaine abstinence
- BEHAVIORAL prize contingency management on a variable interval schedule for cocaine abstinence
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 274 participants |
| Start Date | 2014-08 |
| Est. Completion | 2020-10 |
| Phase | NA |
What the finished NCT02143063 record still lists
NCT02143063 is an interventional study that assigns participants to a tested intervention. The registered 274 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (80% lower).
The record links to 0 conditions, and to 3 interventions - of which standard care is the first listed.
NCT02143063 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02143063 about?
NCT02143063 is a clinical study titled "Extending Long-term Outcomes Through an Adaptive Aftercare Intervention". Reinforcement interventions have pronounced effects on reducing cocaine use. This study will evaluate a novel approach in which reinforcement frequency varies by patient performance. To test efficacy, 280 patients with cocaine use disorder will be randomly assigned to: standard care, standard care p...
What is the current status of trial NCT02143063?
This trial is currently completed. It is a NA study. The enrollment target is 274 participants. The study started on 2014-08. Estimated completion is 2020-10.
What interventions are being tested in trial NCT02143063?
The interventions under investigation include: standard care (BEHAVIORAL), prize contingency management on a traditional twice weekly schedule for cocaine abstinence (BEHAVIORAL), prize contingency management on a variable interval schedule for cocaine abstinence (BEHAVIORAL).
Who is sponsoring clinical trial NCT02143063?
This trial is sponsored by UConn Health, which has 178 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02143063's enrollment target sits among peer trials
274 385th of 2000 higher than 1,615 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03808922 · 274 participants · Phase 3
Phase III DAS181 Lower Tract PIV Infection in Immunocompromised Subjects (Substudy: DAS181 for COVID-19): RCT Study
- NCT04573504 · 274 participants · Phase 4
Antibiotics for Severe Perineal Laceration to Prevent Infection Following Repair
- NCT05289557 · 274 participants · Phase 3
The Efficacy and Safety of Bonjesta® for Nausea and Vomiting of Pregnancy in Pregnant Adolescents
- NCT05952583 · 274 participants
Selective Fetal Growth Restriction in Monochorionic Twins - an International Investigation
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia